{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:11:28Z","timestamp":1790662288516,"version":"4.1.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006831","name":"U.S. Air Force","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease progression include lymphopenia, elevated proinflammatory cytokines and chemokines, accumulation of macrophages and neutrophils in lungs, immune dysregulation, cytokine storms, acute respiratory distress syndrome (ARDS), etc. Development of vaccines to severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome coronavirus (MERS-CoV), and other coronavirus has been difficult to create due to vaccine induced enhanced disease responses in animal models. Multiple betacoronaviruses including SARS-CoV-2 and SARS-CoV-1 expand cellular tropism by infecting some phagocytic cells (immature macrophages and dendritic cells) via antibody bound Fc receptor uptake of virus. Antibody-dependent enhancement (ADE) may be involved in the clinical observation of increased severity of symptoms associated with early high levels of SARS-CoV-2 antibodies in patients. Infants with multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 may also have ADE caused by maternally acquired SARS-CoV-2 antibodies bound to mast cells. ADE risks associated with SARS-CoV-2 has implications for COVID-19 and MIS-C treatments, B-cell vaccines, SARS-CoV-2 antibody therapy, and convalescent plasma therapy for patients. SARS-CoV-2 antibodies bound to mast cells may be involved in MIS-C and multisystem inflammatory syndrome in adults (MIS-A) following initial COVID-19 infection. SARS-CoV-2 antibodies bound to Fc receptors on macrophages and mast cells may represent two different mechanisms for ADE in patients. These two different ADE risks have possible implications for SARS-CoV-2 B-cell vaccines for subsets of populations based on age, cross-reactive antibodies, variabilities in antibody levels over time, and pregnancy. These models place increased emphasis on the importance of developing safe SARS-CoV-2 T cell vaccines that are not dependent upon antibodies.<\/jats:p>","DOI":"10.3389\/fimmu.2021.640093","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:34:42Z","timestamp":1614141282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":114,"title":["Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies"],"prefix":"10.3389","volume":"12","author":[{"given":"Darrell O.","family":"Ricke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.26234","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J Med Virol."},{"key":"B2","unstructured":"CoronavirusCOVID-19 Global Cases by Johns Hopkins CSSE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.biocel.2006.02.003","article-title":"Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT\/enhancer binding protein","volume":"38","author":"Yan","year":"2006","journal-title":"Int J Biochem Cell Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1101\/2020.05.05.20077610","article-title":"Celebrex adjuvant therapy on COVID-19: an experimental study","volume":"11","author":"Hong","year":"2020","journal-title":"Front Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3646583","article-title":"Hospitalized COVID-19 patients treated with celecoxib and high dose famotidine adjuvant therapy show significant clinical responses","author":"Tomera","year":"2020","journal-title":"SSRN [Preprint]."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-30934\/v1","article-title":"COVID-19: famotidine, histamine, mast cells, and mechanisms","author":"Malone","year":"2020","journal-title":"Res Square [Preprint]."},{"key":"B7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/infdis\/jiv380","article-title":"Middle east respiratory syndrome coronavirus efficiently infects human primary t lymphocytes and activates the extrinsic and intrinsic apoptosis pathways","volume":"213","author":"Chu","year":"2015","journal-title":"J Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12985-015-0446-6","article-title":"Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis","volume":"12","author":"Zhou","year":"2015","journal-title":"Virol J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.virol.2014.02.005","article-title":"Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus","author":"Yasui","year":"2014","journal-title":"Virology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-\u03b3-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","volume":"326","author":"Wong","year":"2003","journal-title":"BMJ."},{"key":"B14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1086\/381535","article-title":"Significant changes of peripheral t lymphocyte subsets in patients with severe acute respiratory syndrome","volume":"189","author":"Li","year":"2004","journal-title":"J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1042\/BJ20050698","article-title":"Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors","volume":"392","author":"Yang","year":"2005","journal-title":"Biochem J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"Virol J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am J Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cel Mol Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science."},{"key":"B21","volume-title":"On the Origin of Species","author":"Darwin","year":"1859"},{"key":"B22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/217624a0","article-title":"Evolutionary rate at the molecular level","volume":"217","author":"Kimura","year":"1968","journal-title":"Nature."},{"key":"B23","first-page":"820","article-title":"Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as \u201cspacer\u201d elements","volume":"49","author":"Bottema","year":"1991","journal-title":"Am J Hum Genet."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1101\/045930","article-title":"Divergence model of protein evolution","author":"Ricke","year":"2016","journal-title":"bioRxiv [Preprint]."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.3390\/v4123440","article-title":"Involvement of autophagy in coronavirus replication","volume":"4","author":"Maier","year":"2012","journal-title":"Viruses."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29245\/2578-2940\/2020\/2.1157","article-title":"Kawasaki disease, multisystem inflammatory syndrome in children: antibody-induced mast cell activation hypothesis","volume":"4","author":"Ricke","year":"2020","journal-title":"J Pediatrics Pediatr Med."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1109\/HPEC.2015.7322463","article-title":"Dawn: rapid large-scale protein multiple sequence alignment and conservation analysis","volume-title":"IEEE High Performance Extreme Computing Conference (HPEC)","author":"Ricke","year":"2015"},{"key":"B28","doi-asserted-by":"publisher","first-page":"eabb2507","DOI":"10.1101\/2020.02.11.944462","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"2020","author":"Wrapp","year":"2020","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem."},{"key":"B31","unstructured":"LiuA\n          First Moderna, Now Pfizer-BioNTech Working on Booster Shot Amid Rise of COVID-19 Variants2021"},{"key":"B32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci China Life Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for lineage B \u03b2-coronaviruses, including 2019-nCoV","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1128\/JVI.00671-11","article-title":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway","volume":"85","author":"Jaume","year":"2011","journal-title":"J Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13134","DOI":"10.1128\/JVI.02433-13","article-title":"Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus","volume":"87","author":"Gao","year":"2013","journal-title":"J Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2249.2005.02681.x","article-title":"Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome","volume":"139","author":"Wang","year":"2005","journal-title":"Clin Exp Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1128\/JVI.00851-17","article-title":"In vitro enhancement of respiratory syncytial virus infection by maternal antibodies does not explain disease severity in infants","volume":"91","author":"van Erp","year":"2017","journal-title":"J Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3389\/fmicb.2018.02991","article-title":"Viral-induced enhanced disease illness","volume":"9","author":"Smatti","year":"2018","journal-title":"Front Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.18749.1","article-title":"The long road to protect infants against severe RSV lower respiratory tract illness","volume":"8","author":"Jares Baglivo","year":"2019","journal-title":"F1000Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1073\/pnas.1821317116","article-title":"Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics","volume":"116","author":"Winarski","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/S0140-6736(03)13557-X","article-title":"Lymphopenia in SARS","volume":"361","author":"Panesar","year":"2003","journal-title":"Lancet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1101\/2020.02.06.20020974","article-title":"Clinical characteristics of 2019 novel coronavirus infection in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0378-1119(03)00674-7","article-title":"Isolation and characterization of the human DC-SIGN and DC-SIGNR promoters","volume":"313","author":"Liu","year":"2003","journal-title":"Gene."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1000636","DOI":"10.1371\/journal.ppat.1000636","article-title":"Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice","volume":"5","author":"Zhao","year":"2009","journal-title":"PLoS Pathog."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e123158","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03\/27.20045427","article-title":"The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes","author":"Chen","year":"2020","journal-title":"medRxiv [Preprint]."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.17.300996","article-title":"Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis","author":"Boumaza","year":"2020","journal-title":"bioRxiv [Preprint]"},{"key":"B52","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections: implications for SARS","volume":"5","author":"Dandekar","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type i interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e02015","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3201\/eid1302.060539","article-title":"Neutralizing antibodies after infection with dengue 1 virus","volume":"13","author":"Guzman","year":"2007","journal-title":"Emerg Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science."},{"key":"B57","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science."},{"key":"B58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S2055-6640(20)31216-4","article-title":"SARS coronavirus has antibody-dependent enhancement (ADE) effect through the autologous antibodies against envelope spikes on Fc\u03b3 receptor expressing cells","volume":"2","author":"Yeh","year":"2016","journal-title":"J Virus Erad."},{"key":"B59","doi-asserted-by":"publisher","first-page":"30764","DOI":"10.2139\/ssrn.3680955","article-title":"Genomic evidence for reinfection with SARS-CoV-2: a case study","author":"Tillett","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 \u2014 preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcv.2005.07.005","article-title":"Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome","volume":"35","author":"Lee","year":"2006","journal-title":"J Clin Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/22221751.2020.1773324","article-title":"Patterns of IgG and IgM antibody response in COVID-19 patients","volume":"9","author":"Liu","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B63","doi-asserted-by":"publisher","first-page":"110629","DOI":"10.1016\/j.biopha.2020.110629","article-title":"SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia","volume":"130","author":"Chen","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"ciaa1280","DOI":"10.1093\/cid\/ciaa1280","article-title":"Viral dynamics and immune correlates of COVID-19 disease severity","volume":"2020","author":"Young","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S2213-2600(20)30354-4","article-title":"SARS-CoV-2 viral load predicts COVID-19 mortality","volume":"8","author":"Pujadas","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1389.","article-title":"Kinetics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody avidity maturation and association with disease severity","author":"Luo","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.21203\/rs.3.rs-43878\/v1","article-title":"SARS-CoV-2 viral load is associated with increased disease severity and mortality","volume":"11","author":"Fajnzylber","year":"2020","journal-title":"Nat Commun."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.08.20209114","article-title":"Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis","author":"Wu","year":"2020","journal-title":"medRxiv [Preprint]."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0161-5890(02)00077-9","article-title":"Activation of human mast cells through the high affinity IgG receptor","volume":"38","author":"Tkaczyk","year":"2002","journal-title":"Mol Immunol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B72","unstructured":"MIS-C cases in children connected to COVID-19 surface in Northeast Ohio 2021\n            JordanJ"},{"key":"B73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.32607\/20758251-2019-11-4-22-32","article-title":"Non-neutralizing antibodies directed at conservative influenza antigens","volume":"11","author":"Sedova","year":"2019","journal-title":"Acta Naturae."},{"key":"B74","doi-asserted-by":"publisher","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-Induced Anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS ONE."},{"key":"B76","doi-asserted-by":"publisher","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J Virology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.4049\/jimmunol.181.9.6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","article-title":"Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates","volume":"2","author":"Wang","year":"2016","journal-title":"ACS Infect Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem Biophys Res Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1080\/21645515.2016.1177688","article-title":"Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus","volume":"12","author":"Agrawal","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","article-title":"New vaccine technologies to combat outbreak situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.diagmicrobio.2017.07.006","article-title":"Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity","volume":"89","author":"Ko","year":"2017","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3201\/eid0909.030367","article-title":"Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan","volume":"9","author":"Hsueh","year":"2003","journal-title":"Emerg Infect Dis."},{"key":"B86","unstructured":"MayB\n          Regeneron Halts Enrollment of Critically Ill Patients in COVID-19 Antibody Trial BioSpace2020"},{"key":"B87","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.2020.12607","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening covid-19: a randomized clinical trial","volume":"324","author":"Li","year":"2020","journal-title":"JAMA."},{"key":"B88","doi-asserted-by":"publisher","first-page":"m3939","DOI":"10.1136\/bmj.m3939","article-title":"Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ."},{"key":"B89","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"15092","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat Commun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/JVI.80.2.941-950.2006","article-title":"Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus","volume":"80","author":"Lip","year":"2006","journal-title":"J Virol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jsb.2006.03.019","article-title":"Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus","volume":"155","author":"Tripet","year":"2006","journal-title":"J Struct Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1128\/JVI.79.6.3289-3296.2005","article-title":"Amino acids 1055 to 1192 in the s2 region of severe acute respiratory syndrome coronavirus s protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents","volume":"79","author":"Keng","year":"2005","journal-title":"J Virol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"487","DOI":"10.33218\/001c.12561","article-title":"Precision COVID-19 vaccine with companion diagnostics","volume":"3","author":"Lisziewicz","year":"2020","journal-title":"Prec Nanomed."},{"key":"B95","unstructured":"2020"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.640093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:35:02Z","timestamp":1614141302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.640093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":95,"alternative-id":["10.3389\/fimmu.2021.640093"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.640093","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"article-number":"640093"}}